Antiaging Quantum Living posted a net loss of USD 837,646, widening 16.27% in fiscal 2026.
Revenue rose 26.47% to USD 1.03 million, while operating loss widened 5.75% to USD 835,401.
Gross margin climbed 15.5 percentage points to 67.9%, as selling, general and administrative expenses increased 26.18% to USD 1.54 million.
FY 2026 revenue included USD 141,828 from therapy services and USD 180,950 from proprietary health/beauty products as the company exited online platform technical services.
Cash and cash equivalents totaled about USD 503,486 at March 31, 2026, with a working capital deficit of USD 459,038.